Is Integ. Proteins overvalued or undervalued?

As of 10 November 2025, the valuation grade for Integ. Proteins has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, with a PE ratio of 42.60, an EV to EBIT of 14.06, and a PEG ratio of 0.11, all suggesting that the stock may be trading below its intrinsic value relative to its earnings growth potential.
When compared to peers, Integ. Proteins stands out as attractive against Manorama Industries, which is deemed expensive with a PE of 43.52, and CIAN Agro, also expensive at a PE of 50.51. Additionally, the company's recent stock performance has been strong, with a 1-month return of 65.58%, significantly outperforming the Sensex's 1.25% return, reinforcing the notion that Integ. Proteins is undervalued in the current market landscape.